Expert Panel Discusses U.S. v. Skrmetti and the Future of Health Care
The Solomon Center for Health Law and Policy welcomed a panel of experts on Nov. 20 to discuss the Supreme Court’s June 2025 opinion in United States v. Skrmetti, which upheld a Tennessee law banning gender-affirming hormone therapies for transgender people under 18. The conversation took place before an audience of more than 150 students and faculty from across Yale University. Douglas NeJaime, the Anne Urowsky Professor of Law and the author of a recent article about the decision in the Yale Law Journal forum, moderated.
The panel included speakers working in law and medicine. Joshua Block ’05, senior counsel at the American Civil Liberties Union, addressed the key legal questions Skrmetti left unresolved and litigation trends before and after the decision. Dr. Meredithe McNamara, assistant professor of pediatrics at Yale School of Medicine, discussed the decision’s impact on patients and health care providers. Jess Braverman, legal director at Gender Justice, spoke about state law and policy strategies to increase health care access for children and adolescents.
The event, which concluded with questions from the audience, was co-sponsored by the Yale Health Law and Policy Society (YHeLPS), Yale Law Women+, the American Constitution Society, OutLaws, the Disabled Law Students Association, Trans@YLS, and the If/When/How Yale Law School Chapter.
About the Solomon Center
The Solomon Center for Health Law and Policy at Yale Law School is the first of its kind to focus on the intersection of law and the governance, practice, and business of health care. The center brings together leading experts and practitioners from the public and private sectors to address cutting-edge questions of health law and policy, and to train the next generation of top health lawyers, industry leaders, policymakers, and academics.
